4
Changes in Ownership
HAEMONETICS CORP Filed Acc 0001127602-17-018533
Director sold 8,580 shares at an average $41.49 ($355,982)
- Director acquired 8,580 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| KROLL MARK W Director | 2017-05-15 | Option exercise | +8,580 | $27.24 | $233,719 | 31,014 | D |
| KROLL MARK W Director | 2017-05-15 | Sale | −100 | $41.44 | $4,144 | 30,914 | D |
| KROLL MARK W Director | 2017-05-15 | Sale | −100 | $41.45 | $4,145 | 30,814 | D |
| KROLL MARK W Director | 2017-05-15 | Sale | −200 | $41.45 | $8,290 | 30,614 | D |
| KROLL MARK W Director | 2017-05-15 | Sale | −53 | $41.45 | $2,197 | 30,561 | D |
| KROLL MARK W Director | 2017-05-15 | Sale | −100 | $41.46 | $4,146 | 30,461 | D |
| KROLL MARK W Director | 2017-05-15 | Sale | −500 | $41.46 | $20,730 | 29,961 | D |
| KROLL MARK W Director | 2017-05-15 | Sale | −300 | $41.47 | $12,440 | 29,661 | D |
| KROLL MARK W Director | 2017-05-15 | Sale | −1,771 | $41.47 | $73,443 | 27,890 | D |
| KROLL MARK W Director | 2017-05-15 | Sale | −300 | $41.48 | $12,443 | 27,590 | D |
| KROLL MARK W Director | 2017-05-15 | Sale | −1,900 | $41.48 | $78,812 | 25,690 | D |
| KROLL MARK W Director | 2017-05-15 | Sale | −300 | $41.49 | $12,446 | 25,390 | D |
| KROLL MARK W Director | 2017-05-15 | Sale | −100 | $41.49 | $4,149 | 25,290 | D |
| KROLL MARK W Director | 2017-05-15 | Sale | −100 | $41.50 | $4,150 | 25,190 | D |
| KROLL MARK W Director | 2017-05-15 | Sale | −453 | $41.50 | $18,800 | 24,737 | D |
| KROLL MARK W Director | 2017-05-15 | Sale | −276 | $41.51 | $11,455 | 24,461 | D |
| KROLL MARK W Director | 2017-05-15 | Sale | −818 | $41.52 | $33,963 | 23,643 | D |
| KROLL MARK W Director | 2017-05-15 | Sale | −129 | $41.53 | $5,357 | 23,514 | D |
| KROLL MARK W Director | 2017-05-15 | Sale | −273 | $41.54 | $11,340 | 23,241 | D |
| KROLL MARK W Director | 2017-05-15 | Sale | −100 | $41.55 | $4,155 | 23,141 | D |
| KROLL MARK W Director | 2017-05-15 | Sale | −400 | $41.55 | $16,620 | 22,741 | D |
| KROLL MARK W Director | 2017-05-15 | Sale | −307 | $41.56 | $12,759 | 22,434 | D |
| Derivatives | |||||||
| KROLL MARK W Director | 2017-05-15 | Option exercise · Non-qualified Stock Option (Right to Buy) | −8,580 | 0 | D | ||
| Open-market sales · 8,580 sh · avg $41.49 · $355,982 | |||||||
Loading xslF345X03/form4.xml…